BioSyent Inc. (TSXV:RX)
Canada · Delayed Price · Currency is CAD 14.50
+0.45 (3.20%)
Jun 29, 2026, 11:38 AM EST
BioSyent Market Cap
BioSyent has a market cap or net worth of CAD 160.71 million as of June 29, 2026. Its market cap has increased by 23.63% in one year.
Market Cap
160.71M
Enterprise Value
155.06M
Revenue
45.98M
Ranking
n/a
PE Ratio
17.92
Stock Price
14.50
Market Cap Chart
Since April 24, 1997, BioSyent's market cap has increased from 13.21M to 160.71M, an increase of 1,116.96%. That is a compound annual growth rate of 8.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 160.71M | 12.09% |
| Dec 31, 2025 | 143.37M | 12.27% |
| Dec 31, 2024 | 127.69M | 17.76% |
| Dec 29, 2023 | 108.44M | 28.05% |
| Dec 30, 2022 | 84.69M | -18.50% |
| Dec 30, 2021 | 103.91M | 2.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TerrAscend | 290.99M |
| Auxly Cannabis Group | 265.21M |
| Aurora Cannabis | 250.87M |
| Organigram Global | 205.53M |
| Cardiol Therapeutics | 174.06M |
| Cannara Biotech | 165.95M |
| Ascend Wellness Holdings | 143.99M |
| Grown Rogue International | 142.47M |